Disitamab Vedotin Alone or in Combination With Immune Checkpoint Inhibitors in Bladder-Sparing Treatment of Muscle-Invasive Bladder Cancer: A Real-World Study
Anbang Wang, Ming Chen, Duocai Li, Jiazi Shi, Wenbin Tang, Zongqin Zhang, Shancheng Ren
Topics & Concepts
MedicineBladder cancerOncologyInternal medicineUrologyCancerBladder and Urothelial Cancer TreatmentsTissue Engineering and Regenerative MedicineUrinary and Genital Oncology Studies